NABI BIOPHARMACEUTICALS 12276 Wilkins Avenue Rockville, Maryland 20852 Dated January 22, 2008Employment Agreement • May 8th, 2008 • Nabi Biopharmaceuticals • Biological products, (no disgnostic substances) • Maryland
You have agreed to serve as the President and Chief Executive Officer of Nabi Biopharmaceuticals (“Nabi”) commencing on January 22, 2008 (the “Effective Date”), in accordance with the following terms of your employment by Nabi. This Employment Agreement (the “Agreement”) supersedes and replaces your Employment Agreement dated effective as of May 18, 2007 between you and Nabi and your Change of Control Severance Agreement dated as of April 1, 2004 between you and Nabi.
Nabi Biopharmaceuticals 12276 Wilkins Avenue Rockville MD 20852 February 27, 2008Nabi Biopharmaceuticals • May 8th, 2008 • Biological products, (no disgnostic substances)
Reference is made to the following agreements between you (the “Executive”) and Nabi Biopharmaceuticals (“Nabi”) (collectively, the “Nabi Agreements”): (a) that certain Employment Agreement, dated as of April 29, 2006 (the “Nabi Employment Agreement”); (b) that certain Change of Control Severance Agreement, dated as of April 29, 2006; (c) that certain Relocation, Sign-On Bonus Repayment Agreement, dated as of April 29, 2006 (the “Sign-On Agreement”); (d) that certain Indemnification Agreement, dated as of April 29, 2006; and (e) those certain stock option and restricted stock agreements between the Executive and Nabi under the 2007 Omnibus Equity and Incentive Plan and the Executive’s inducement stock option and restricted stock agreements dated June 12, 2006 (the “Equity Agreements”).
